Pliant Return On Equity from 2010 to 2024
| PLRX Stock | USD 12.88 0.15 1.18% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter (0.34) | Current Value (0.32) | Quarterly Volatility 17.55093952 |
Check Pliant TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pliant main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Net Interest Income of 20.2 M or Interest Income of 21.5 M, as well as many exotic indicators such as Price To Sales Ratio of 707, Dividend Yield of 0.0 or PTB Ratio of 2.36. Pliant financial statements analysis is a perfect complement when working with Pliant TherapeuticsInc Valuation or Volatility modules.
Pliant | Return On Equity |
Latest Pliant TherapeuticsInc's Return On Equity Growth Pattern
Below is the plot of the Return On Equity of Pliant TherapeuticsInc over the last few years. Return on Equity is the amount of Pliant TherapeuticsInc net income returned as a percentage of Pliant TherapeuticsInc equity. Return on equity measures Pliant TherapeuticsInc profitability by revealing how much profit Pliant TherapeuticsInc generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. Pliant TherapeuticsInc's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pliant TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported -0.34 | 10 Years Trend |
|
Return On Equity |
| Timeline |
Pliant Return On Equity Regression Statistics
| Arithmetic Mean | 20.48 | |
| Geometric Mean | 4.77 | |
| Coefficient Of Variation | 85.69 | |
| Mean Deviation | 16.61 | |
| Median | 34.33 | |
| Standard Deviation | 17.55 | |
| Sample Variance | 308.04 | |
| Range | 34.7518 | |
| R-Value | (0.85) | |
| Mean Square Error | 91.73 | |
| R-Squared | 0.72 | |
| Significance | 0.000059 | |
| Slope | (3.34) | |
| Total Sum of Squares | 4,312 |
Pliant Return On Equity History
About Pliant TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Pliant TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Pliant TherapeuticsInc investors use historical funamental indicators, such as Pliant TherapeuticsInc's Return On Equity, to determine how well the company is positioned to perform in the future. Although Pliant TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Pliant TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Pliant TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Pliant TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Pliant TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (0.34) | (0.32) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Pliant TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pliant TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pliant Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pliant Therapeuticsinc Stock:Check out the analysis of Pliant TherapeuticsInc Correlation against competitors. For more information on how to buy Pliant Stock please use our How to Invest in Pliant TherapeuticsInc guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Pliant Stock analysis
When running Pliant TherapeuticsInc's price analysis, check to measure Pliant TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant TherapeuticsInc is operating at the current time. Most of Pliant TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Pliant TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant TherapeuticsInc's price. Additionally, you may evaluate how the addition of Pliant TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Pliant TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pliant TherapeuticsInc. If investors know Pliant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pliant TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.90) | Revenue Per Share 0.004 | Quarterly Revenue Growth (1.00) | Return On Assets (0.22) | Return On Equity (0.34) |
The market value of Pliant TherapeuticsInc is measured differently than its book value, which is the value of Pliant that is recorded on the company's balance sheet. Investors also form their own opinion of Pliant TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Pliant TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pliant TherapeuticsInc's market value can be influenced by many factors that don't directly affect Pliant TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pliant TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pliant TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pliant TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.